Welcome to our dedicated page for ETHZilla Corporation news (Ticker: ETHZ), a resource for investors and traders seeking the latest updates and insights on ETHZilla Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ETHZilla Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ETHZilla Corporation's position in the market.
ETHZilla Corporation (NASDAQ: ETHZ), formerly 180 Life Sciences Corp. (NASDAQ: ATNF), announced a major rebranding and strategic shift to focus on Ethereum treasury operations. The company's stock will begin trading under the new ticker ETHZ on August 18, 2025.
The company has successfully raised $565 million through private placements, including a $425 million PIPE and $156.25 million convertible note offering. ETHZilla has already accumulated 94,675 ETH at an average price of $3,902.20, currently valued at approximately $419 million, with an additional $187 million in cash equivalents.
Electric Capital will serve as the external asset manager, implementing an on-chain yield generation program combining staking, lending, and liquidity provisioning. The private placement attracted over 60 institutional and crypto-native investors, including prominent Ethereum ecosystem leaders.